What has the universal birth dose [of the hepatitis B vaccine] accomplished, compared to more targeted measures, which could include selective vaccination of at-risk populations or non-pharmaceutical public health programs? And the answer there is, surprisingly, that it’s the more targeted measures that have had the biggest effect in bringing down cases of hepatitis B.
If you would like to receive an e-mail notice of the most recent articles published in The Vaccine Reaction each week, click here.
